Pancreatic Cancer Research

ResearcherUniversity Medical Center Hamburg-EppendorfNo recent work listed

Christian Moser

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4560-7028; OpenAlex author ID A5024998614. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2011: 2 papers · 2012: 2 papers

Papers 4

  1. STAT5b as molecular target in pancreatic cancer--inhibition of tumor growth, angiogenesis, and metastases. Co-author DOI 10.1593/neo.12878↗
  2. Targeting HSP90 by the novel inhibitor NVP-AUY922 reduces growth and angiogenesis of pancreatic cancer. Co-author PMID 22753713↗
  3. Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer. Co-author DOI 10.1111/j.1349-7006.2011.01917.x↗
  4. Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial cells, and pericytes in pancreatic cancer. First author DOI 10.1158/1535-7163.mct-11-0312↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sven Arke Lang · 4 shared papers, 2011–2012 · strength 0.11
  2. Oliver Stoeltzing · 3 shared papers, 2011–2012 · strength 0.09
  3. Christina Hackl · 2 shared papers, 2012 · strength 0.06
  4. Karl‐Hermann Schlingensiepen · 1 shared paper, 2011 · strength 0.03
  5. Anneliese Schneider · 1 shared paper, 2011 · strength 0.03
  6. Johannes Taeger · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.